#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15172	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2283	661.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1617	1617	C	891	C	847	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26722	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3581	743.8	0	.	n	.	0	T695C	SNP	695	695	T	1066	1066	C	799	C	742	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26722	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3581	743.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	2009	2009	G	843	G,A	793,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26722	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3581	743.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2342	2342	C	845	C	798	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26722	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3581	743.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2416	2416	A	895	A	841	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26722	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3581	743.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2968	2968	C	829	C	779	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	1710	folP	852	852	99.77	folP.l15.c4.ctg.1	1612	105.8	0	.	p	.	0	S68P	NONSYN	202	204	TCG	586	588	CCG	157;156;156	C,A;C;G	144,1;142;142	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	1710	folP	852	852	99.77	folP.l15.c4.ctg.1	1612	105.8	0	.	p	.	0	A204V	NONSYN	610	612	GCA	994	996	GTA	174;174;176	G;T,C;A	168;166,1;169	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	1710	folP	852	852	99.77	folP.l15.c4.ctg.1	1612	105.8	1	SNP	p	R228S	1	.	.	682	684	AGC	1066	1068	AGC	174;175;178	A;G;C	162;162;164	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5628	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3222	173.5	1	SNP	p	S91F	1	.	.	271	273	TTC	515	517	TTC	212;212;211	T;T;C	193;196;194	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5628	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3222	173.5	1	SNP	p	G95N	0	.	.	283	285	GGC	527	529	GGC	204;200;199	G;G;C	187;185;183	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5628	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3222	173.5	1	SNP	p	D95G	1	.	.	283	285	GGC	527	529	GGC	204;200;199	G;G;C	187;185;183	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1580	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1380	114.1	1	SNP	p	G45D	0	.	.	133	135	GGC	508	510	GGC	194;192;195	G;G;C	177;178;178	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	764	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1087	70.0	0	.	n	.	0	A197.	DEL	197	197	A	599	599	A	176	A	167	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5576	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3050	182.1	1	SNP	p	D86N	0	.	.	256	258	GAC	606	608	GAC	221;220;223	G;A;C	209;206;212	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5576	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3050	182.1	1	SNP	p	R87I	0	.	.	259	261	CGT	609	611	CGT	223;223;227	C;G;T	214;213;214	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5576	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3050	182.1	1	SNP	p	R87W	0	.	.	259	261	CGT	609	611	CGT	223;223;227	C;G;T	214;213;214	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5576	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3050	182.1	1	SNP	p	S87R	1	.	.	259	261	CGT	609	611	CGT	223;223;227	C;G;T	214;213;214	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5576	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3050	182.1	1	SNP	p	S88P	0	.	.	262	264	TCC	612	614	TCC	228;229;231	T;C,A;C,A	216;218,1;220,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3826	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2732	139.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1561	1563	GGC	173;171;170	G,A;G;C	162,1;157;156	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3768	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2443	153.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1303	1305	GCC	191;189;188	G;C;C	179;176;176	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3768	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2443	153.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1306	1308	ATG	186;187;189	A;T,C;G	175;172,2;179	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3768	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2443	153.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1318	1320	ACC	186;186;185	A;C;C	172;172;174	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3768	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2443	153.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1318	1320	ACC	186;186;185	A;C;C	172;172;174	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3768	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2443	153.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1819	1821	ACC	199;196;198	A;C;C	182;184;188	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3768	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2443	153.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1873	1875	GCG	186;186;187	G;C;G	174;174;172	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3768	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2443	153.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1873	1875	GCG	186;186;187	G;C;G	174;174;172	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3768	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2443	153.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1996	1998	GGT	163;165;165	G;G;T,A	152;152;147,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3768	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2443	153.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2005	2007	AGC	165;162;161	A;G;C	149;148;147	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3768	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2443	153.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2023	2025	CCG	150;154;155	C,G;C,G;G	111,4;114,2;116	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5726	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3196	178.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1675	1677	CCG	193;190;191	C;C;G	171;171;170	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2220	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1976	111.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	617	617	C	151	C	134	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	286	porB1a	984	297	91.03	porB1a.l6.c30.ctg.2	349	26.7	0	.	p	.	0	H217N	NONSYN	649	651	CAT	73	75	AAT	15;15;15	A;A;T	15;15;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	286	porB1a	984	297	91.03	porB1a.l6.c30.ctg.2	349	26.7	0	.	p	.	0	D218N	NONSYN	652	654	GAT	76	78	AAT	15;15;15	A;A;T	15;15;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	286	porB1a	984	297	91.03	porB1a.l6.c30.ctg.2	349	26.7	0	.	p	.	0	V226A	NONSYN	676	678	GTA	100	102	GCA	17;16;15	G;C;A	17;16;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	286	porB1a	984	297	91.03	porB1a.l6.c30.ctg.2	349	26.7	0	.	p	.	0	.	MULTIPLE	700	702	ACT	123	125	GTA	15;15;14	G;T;A	15;15;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	286	porB1a	984	297	91.03	porB1a.l6.c30.ctg.2	349	26.7	0	.	p	.	0	N237fs	FSHIFT	709	709	A	132	132	A	13	A	13	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2944	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1631	179.1	1	SNP	p	G120K	1	.	.	358	360	AAG	663	665	AAG	220;217;219	A;A;G	210;209;208	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2944	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1631	179.1	1	SNP	p	A121N	1	.	.	361	363	AAC	666	668	AAC	219;216;211	A,G;A;C	210,1;209;204	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2944	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1631	179.1	1	SNP	p	N121D	0	.	.	361	363	AAC	666	668	AAC	219;216;211	A,G;A;C	210,1;209;204	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10890	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5085	213.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1270	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	977	128.0	1	SNP	p	V57M	1	.	.	169	171	ATG	479	481	ATG	269;267;267	A;T;G,C	259;253;253,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
